Literature DB >> 23122779

A conserved interdomain communication pathway of pseudosymmetrically distributed residues affects substrate specificity of the fungal multidrug transporter Cdr1p.

Marcin Kolaczkowski1, Kamila Sroda-Pomianek, Anna Kolaczkowska, Krystyna Michalak.   

Abstract

Understanding the communication pathways between remote sites in proteins is of key importance for understanding their function and mechanism of action. These remain largely unexplored among the pleiotropic drug resistance (PDR) representatives of the ubiquitous superfamily of ATP-binding cassette (ABC) transporters. To identify functionally coupled residues important for the polyspecific transport by the fungal ABC multidrug transporter Cdr1p a new selection strategy, towards increased resistance to a preferred substrate of the homologous Snq2p, was applied to a library of randomly generated mutants. The single amino acid substitutions, located pseudosymmetrically in each domain of the internally duplicated protein: the H-loop of the N-terminal nucleotide binding domain (NBD1) (C363R) and in the C-terminal NBD2 region preceding Walker A (V885G). The central regions of the first transmembrane helices 1 and 7 of both transmembrane domains were also affected by the G521S/D and A1208V substitutions respectively. Although the mutants were expressed at a similar level and located correctly to the plasma membrane, they selectively affected transport of multiple drugs, including azole antifungals. The synergistic effects of combined mutations on drug resistance, drug dependent ATPase activity and transport support the view inferred from the statistical coupling analysis (SCA) of aminoacid coevolution and mutational analysis of other ABC transporter families that these residues are an important part of the conserved, allosterically coupled interdomain communication network. Our results shed new light on the communication between the pseudosymmetrically arranged domains in a fungal PDR ABC transporter and reveal its profound influence on substrate specificity.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23122779     DOI: 10.1016/j.bbamem.2012.10.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  The deviant ATP-binding site of the multidrug efflux pump Pdr5 plays an active role in the transport cycle.

Authors:  Christopher Furman; Jitender Mehla; Neeti Ananthaswamy; Nidhi Arya; Bridget Kulesh; Ildiko Kovach; Suresh V Ambudkar; John Golin
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

2.  An A666G mutation in transmembrane helix 5 of the yeast multidrug transporter Pdr5 increases drug efflux by enhancing cooperativity between transport sites.

Authors:  Nidhi Arya; Hadiar Rahman; Andrew Rudrow; Manuel Wagner; Lutz Schmitt; Suresh V Ambudkar; John Golin
Journal:  Mol Microbiol       Date:  2019-07-23       Impact factor: 3.501

Review 3.  The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters.

Authors:  John Golin; Suresh V Ambudkar
Journal:  Biochem J       Date:  2015-05-01       Impact factor: 3.857

4.  FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops.

Authors:  Koichi Tanabe; Michele Bonus; Susumu Tomiyama; Kunji Miyoshi; Minoru Nagi; Kyoko Niimi; Ariya Chindamporn; Holger Gohlke; Lutz Schmitt; Richard D Cannon; Masakazu Niimi; Erwin Lamping
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

5.  Role of Ectopic Gene Conversion in the Evolution of a Candida krusei Pleiotropic Drug Resistance Transporter Family.

Authors:  Erwin Lamping; Jing-Yi Zhu; Masakazu Niimi; Richard David Cannon
Journal:  Genetics       Date:  2017-02-03       Impact factor: 4.562

6.  Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition.

Authors:  Masakazu Niimi; Kyoko Niimi; Koichi Tanabe; Richard D Cannon; Erwin Lamping
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.191

7.  Disease-relevant mutations alter amino acid co-evolution networks in the second nucleotide binding domain of CFTR.

Authors:  Gabrianne Ivey; Robert T Youker
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

8.  Nonsynonymous Mutations in Linker-2 of the Pdr5 Multidrug Transporter Identify a New RNA Stability Element.

Authors:  Hadiar Rahman; Andrew Rudrow; Joshua Carneglia; Sister Stephen Patrick Joly; Dante Nicotera; Michael Naldrett; John Choy; Suresh V Ambudkar; John Golin
Journal:  G3 (Bethesda)       Date:  2020-01-07       Impact factor: 3.154

9.  Characterization of the nucleotide-binding domain NsrF from the BceAB-type ABC-transporter NsrFP from the human pathogen Streptococcus agalactiae.

Authors:  Fabia Furtmann; Nicola Porta; Dai Tri Hoang; Jens Reiners; Julia Schumacher; Julia Gottstein; Holger Gohlke; Sander H J Smits
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.